The American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing physicians who treat people with cancer, has appointed Dr. Richard Lauer, executive medical director of the UNM Cancer Center, to its Clinical Practice Committee. The committee oversees the practice of oncology, creates cancer care practice guidelines, and oversees the treatment and care of cancer patients nationwide.
“We are thrilled that one of our very own physicians was appointed to ASCO’s Clinical Practice Committee,” said Dr. Willman, director and CEO of the UNM Cancer Center. “This is a very prestigious appointment as only a few physicians nationwide are selected to serve on this committee. Dr. Richard Lauer’s appointment is a testament to the quality cancer care and treatment provided at the UNM Cancer Center.”
“Working in oncology for 25 years, it is a great honor and privilege to serve on such a prestigious committee as the Clinical Practice Steering Subcommittee,” said Dr. Richard Lauer, executive medical director of the UNM Cancer Center. “The committee allows physicians to represent their patients and cancer communities in order to improve treatment and care for people who are affected by the disease. Being familiar with cancer care in New Mexico, I hope to act as an advocate for all cancer patients in the state.”
In addition, Dr. Richard Lauer was selected to represent New Mexico as part of the Clinical Practice Steering Subcommittee which guides the direction and objectives of the Full Clinical Practice Committee and sets the agenda for committee meetings and events. Dr. Richard Lauer was one of only ten physicians nationwide selected by Dr. George Sledge, president of the American Society of Clinical Oncology, to serve as part Clinical Practice Steering Subcommittee.
# # #